Precision treatment of beta-cell monogenic diabetes: a systematic review.

Rochelle N NaylorKashyap Amratlal Patel Jarno L T KettunenJonna M E MännistöJulie StøyJacques BeltrandMichel Polaknull nullTina VilsbøllSiri Atma W GreeleyAndrew T HattersleyTiinamaija Tuomi

Published in: Communications medicine (2024)

There is limited evidence, and with moderate or serious risk of bias, to guide monogenic diabetes treatment. Further evidence is needed to examine the optimum treatment in monogenic subtypes.

Keyphrases

type diabetes
cardiovascular disease
metabolic syndrome
mesenchymal stem cells
glycemic control
insulin resistance
high intensity
weight loss